Type 2 diabetes prevention. Experts' Group position paper endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy
Magdalena Walicka(Central Clinical Hospital), Edward Franek, Beata Wożakowska−Kapłon(Jan Kochanowski University), Tomasz Chomiuk(Medical University of Warsaw), Magdalena Olszanecka‐Glinianowicz(Medical University of Silesia), Mariusz Wyleżoł(Wojskowy Instytut Medycyny Lotniczej), Artur Mamcarz(Medical University of Warsaw), Krzysztof J. Filipiak
Cited by 3
Related Papers
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
Lactate dehydrogenase level as a COVID-19 severity marker
|The American Journal of Emergency Medicine|2020|109
Physical activity in metabolic syndrome
|Frontiers in Physiology|2024|89